1550 related articles for article (PubMed ID: 19376687)
1. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
[TBL] [Abstract][Full Text] [Related]
2. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.
Borecká-Melkusová S; Moran GP; Sullivan DJ; Kucharíková S; Chorvát D; Bujdáková H
Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475
[TBL] [Abstract][Full Text] [Related]
3. Iron deprivation induces EFG1-mediated hyphal development in Candida albicans without affecting biofilm formation.
Hameed S; Prasad T; Banerjee D; Chandra A; Mukhopadhyay CK; Goswami SK; Lattif AA; Chandra J; Mukherjee PK; Ghannoum MA; Prasad R
FEMS Yeast Res; 2008 Aug; 8(5):744-55. PubMed ID: 18547332
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of two different methods for the investigation of in vitro susceptibilities of planktonic and biofilm forming Candida species to antifungal agents].
Kaynak Onurdağ F; Ozgen S; Abbasoğlu U; Gürcan IS
Mikrobiyol Bul; 2010 Oct; 44(4):619-31. PubMed ID: 21063974
[TBL] [Abstract][Full Text] [Related]
5. Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms.
Seneviratne CJ; Jin LJ; Samaranayake YH; Samaranayake LP
Antimicrob Agents Chemother; 2008 Sep; 52(9):3259-66. PubMed ID: 18625775
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of Candida biofilms to histatin 5 and fluconazole.
Konopka K; Dorocka-Bobkowska B; Gebremedhin S; Düzgüneş N
Antonie Van Leeuwenhoek; 2010 May; 97(4):413-7. PubMed ID: 20140514
[TBL] [Abstract][Full Text] [Related]
7. Techniques for antifungal susceptibility testing of Candida albicans biofilms.
Ramage G; López-Ribot JL
Methods Mol Med; 2005; 118():71-9. PubMed ID: 15888936
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
[TBL] [Abstract][Full Text] [Related]
9. Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans.
Messier C; Grenier D
Mycoses; 2011 Nov; 54(6):e801-6. PubMed ID: 21615543
[TBL] [Abstract][Full Text] [Related]
10. Quantitative evaluation of tissue invasion by wild type, hyphal and SAP mutants of Candida albicans, and non-albicans Candida species in reconstituted human oral epithelium.
Jayatilake JA; Samaranayake YH; Cheung LK; Samaranayake LP
J Oral Pathol Med; 2006 Sep; 35(8):484-91. PubMed ID: 16918600
[TBL] [Abstract][Full Text] [Related]
11. Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole.
Bruzual I; Riggle P; Hadley S; Kumamoto CA
J Antimicrob Chemother; 2007 Mar; 59(3):441-50. PubMed ID: 17261564
[TBL] [Abstract][Full Text] [Related]
12. Comparisons of the susceptibilities of planktonic and adherent Candida albicans to antifungal agents: a modified XTT tetrazolium assay using synchronised C. albicans cells.
Hawser S
J Med Vet Mycol; 1996; 34(2):149-52. PubMed ID: 8732362
[TBL] [Abstract][Full Text] [Related]
13. The inhibitory activity of linalool against the filamentous growth and biofilm formation in Candida albicans.
Hsu CC; Lai WL; Chuang KC; Lee MH; Tsai YC
Med Mycol; 2013 Jul; 51(5):473-82. PubMed ID: 23210679
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional response to fluconazole and amphotericin B in Candida albicans biofilms.
Nailis H; Vandenbosch D; Deforce D; Nelis HJ; Coenye T
Res Microbiol; 2010 May; 161(4):284-92. PubMed ID: 20170727
[TBL] [Abstract][Full Text] [Related]
15. Tricyclic antidepressants inhibit Candida albicans growth and biofilm formation.
Caldara M; Marmiroli N
Int J Antimicrob Agents; 2018 Oct; 52(4):500-505. PubMed ID: 29990546
[TBL] [Abstract][Full Text] [Related]
16. Synergistic activity of lysozyme and antifungal agents against Candida albicans biofilms on denture acrylic surfaces.
Samaranayake YH; Cheung BP; Parahitiyawa N; Seneviratne CJ; Yau JY; Yeung KW; Samaranayake LP
Arch Oral Biol; 2009 Feb; 54(2):115-26. PubMed ID: 19038377
[TBL] [Abstract][Full Text] [Related]
17. New synthetic sulfone derivatives inhibit growth, adhesion and the leucine arylamidase APE2 gene expression of Candida albicans in vitro.
Staniszewska M; Bondaryk M; Ochal Z
Bioorg Med Chem; 2015 Jan; 23(2):314-21. PubMed ID: 25515956
[TBL] [Abstract][Full Text] [Related]
18. Efg1 involved in drug resistance by regulating the expression of ERG3 in Candida albicans.
Lo HJ; Wang JS; Lin CY; Chen CG; Hsiao TY; Hsu CT; Su CL; Fann MJ; Ching YT; Yang YL
Antimicrob Agents Chemother; 2005 Mar; 49(3):1213-5. PubMed ID: 15728931
[TBL] [Abstract][Full Text] [Related]
19. Human oral keratinocyte E-cadherin degradation by Candida albicans and Candida glabrata.
Pärnänen P; Meurman JH; Samaranayake L; Virtanen I
J Oral Pathol Med; 2010 Mar; 39(3):275-8. PubMed ID: 20359311
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of drug-resistance genes in Candida albicans biofilms in response to antifungals.
Watamoto T; Samaranayake LP; Egusa H; Yatani H; Seneviratne CJ
J Med Microbiol; 2011 Sep; 60(Pt 9):1241-1247. PubMed ID: 21474609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
